Inclusion of this control group avoids the detection of candidate TB biomarkers that are non-specific inflammatory markers that cannot differentiate among symptomatic states, as observed with CRP, SAA1, SAA2, SAA3, and SAA4, and which were included in previous plasma proteomic biosignatures7,13. The gene discussed is SAA3P; the disease is tuberculosis.